We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oscar Health, Inc. (OSCR) Stock Dips While Market Gains: Key Facts
Read MoreHide Full Article
In the latest trading session, Oscar Health, Inc. (OSCR - Free Report) closed at $21.80, marking a -2.98% move from the previous day. This change lagged the S&P 500's daily gain of 0.58%.
Coming into today, shares of the company had gained 12.07% in the past month. In that same time, the Finance sector gained 1.07%, while the S&P 500 gained 3.68%.
Analysts and investors alike will be keeping a close eye on the performance of Oscar Health, Inc. in its upcoming earnings disclosure. The company is expected to report EPS of -$0.55, down 150% from the prior-year quarter. Alongside, our most recent consensus estimate is anticipating revenue of $3.09 billion, indicating a 27.51% upward movement from the same quarter last year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of -$1.42 per share and a revenue of $12.06 billion, signifying shifts of -1520% and +31.44%, respectively, from the last year.
Investors should also take note of any recent adjustments to analyst estimates for Oscar Health, Inc. These revisions help to show the ever-changing nature of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Currently, Oscar Health, Inc. is carrying a Zacks Rank of #5 (Strong Sell).
The Insurance - Multi line industry is part of the Finance sector. Currently, this industry holds a Zacks Industry Rank of 85, positioning it in the top 35% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Oscar Health, Inc. (OSCR) Stock Dips While Market Gains: Key Facts
In the latest trading session, Oscar Health, Inc. (OSCR - Free Report) closed at $21.80, marking a -2.98% move from the previous day. This change lagged the S&P 500's daily gain of 0.58%.
Coming into today, shares of the company had gained 12.07% in the past month. In that same time, the Finance sector gained 1.07%, while the S&P 500 gained 3.68%.
Analysts and investors alike will be keeping a close eye on the performance of Oscar Health, Inc. in its upcoming earnings disclosure. The company is expected to report EPS of -$0.55, down 150% from the prior-year quarter. Alongside, our most recent consensus estimate is anticipating revenue of $3.09 billion, indicating a 27.51% upward movement from the same quarter last year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of -$1.42 per share and a revenue of $12.06 billion, signifying shifts of -1520% and +31.44%, respectively, from the last year.
Investors should also take note of any recent adjustments to analyst estimates for Oscar Health, Inc. These revisions help to show the ever-changing nature of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Currently, Oscar Health, Inc. is carrying a Zacks Rank of #5 (Strong Sell).
The Insurance - Multi line industry is part of the Finance sector. Currently, this industry holds a Zacks Industry Rank of 85, positioning it in the top 35% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.